Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Parasitic Diseases

Free Subscription Articles published in Exp Parasitol Retrieve available abstracts of 57 articles: HTML format

Single Articles

October 2025
1. MACHIN L, Napoles R, Tamargo B, Yglesias-Rivera A, et al
   In vitro and in vivo activity of a lipid-based artemisinin formulation against Leishmania (Leishmania) amazonensis.
   Exp Parasitol. 2025 Oct 8:109032. doi: 10.1016/j.exppara.2025.109032.
   PubMed     Abstract available
   
   
   September 2025
2. ALI MT, Rahman T, Palit P, Uddin MI, et al
   Targeting the zinc metalloprotease gp63 of Leishmania for vaccine design and new drug discovery using immunoinformatics, molecular docking and molecular dynamics simulation studies.
   Exp Parasitol. 2025 Sep 2:109009. doi: 10.1016/j.exppara.2025.109009.
   PubMed     Abstract available
   
   
   August 2025
3. VALENTINI MB, Mendes TMF, Allegretti SM
   Comparison of three Schistosoma mansoni strains: Infection, Morphometry and Susceptibility to treatment.
   Exp Parasitol. 2025 Aug 9:109001. doi: 10.1016/j.exppara.2025.109001.
   PubMed     Abstract available
   
   
   
4. ONA KAL, Angeles JMM, Villacorte EA, Balboa KTM, et al
   Preliminary evaluation of the recombinant Sj14-3-3 protein as an immunodiagnostic antigen for schistosomiasis.
   Exp Parasitol. 2025;276:109000.
   PubMed     Abstract available
   
   
   June 2025
5. SOARES OLIVEIRA BA, Silva Coelho PR, Peixoto Moreira JM, Alves MA, et al
   Towards effective and efficient machine learning models for Schistosomiasis diagnosis in microscopic images.
   Exp Parasitol. 2025 Jun 25:108967. doi: 10.1016/j.exppara.2025.108967.
   PubMed     Abstract available
   
   
   
6. CAMARA RSB, Silva AL, Freitas CS, Lage DP, et al
   Urine- and serum-based ELISA using a new recombinant chimeric protein to diagnose tegumentary and visceral leishmaniasis: a preliminary study.
   Exp Parasitol. 2025 Jun 23:108980. doi: 10.1016/j.exppara.2025.108980.
   PubMed     Abstract available
   
   
   
7. LEON E, Hoyos MM, Ramirez-Hernandez MH, Tellez J, et al
   Upregulation of nicotinamide/nicotinate mononucleotide adenylyl transferase increases resistance to oxidative stress and antimony in promastigotes of Leishmania braziliensis.
   Exp Parasitol. 2025 Jun 21:108979. doi: 10.1016/j.exppara.2025.108979.
   PubMed     Abstract available
   
   
   May 2025
8. COUTO DE BARROS T, Vilela RDV, Gentile R, Varella K, et al
   Praziquantel effect on genetic diversity of wild rodent-derived Schistosoma mansoni in experimentally infected mice.
   Exp Parasitol. 2025 May 30:108963. doi: 10.1016/j.exppara.2025.108963.
   PubMed     Abstract available
   
   
   
9. ALMEIDA PASSOS VHA, Souza Leal PPM, Lima Neta PP, Melo ECS, et al
   Topical formulation of Oseltamivir promotes clinical improvement and reduction of parasite load in BALB/c mice infected with Leishmania major.
   Exp Parasitol. 2025 May 27:108966. doi: 10.1016/j.exppara.2025.108966.
   PubMed     Abstract available
   
   
   April 2025
10. SARANGI S, Mahapatra RK
    Identification of therapeutics against PfPK6 protein of Plasmodium falciparum: Structure and Deep Learning approach.
    Exp Parasitol. 2025 Apr 25:108947. doi: 10.1016/j.exppara.2025.108947.
    PubMed     Abstract available
    
    
    
11. MURIITHI B, Chepngetich J, Gachie B, Thiong'o K, et al
    Structural and functional implications of MIT2 and NT2 mutations in amodiaquine and piperaquine resistant Plasmodium berghei parasites.
    Exp Parasitol. 2025;271:108923.
    PubMed     Abstract available
    
    
    March 2025
12. BENIWAL P, Bhusal CK, Choudhary G, Sehgal R, et al
    In silico screening and Molecular Dynamic simulations of FDA-Approved drugs as an inhibitor of Trypanothione Reductase of Leishmania donovani.
    Exp Parasitol. 2025 Mar 26:108942. doi: 10.1016/j.exppara.2025.108942.
    PubMed     Abstract available
    
    
    
13. DE O LOPES M, Dos Reis LFC, de Araujo MP, Castro AP, et al
    Impact of combination chemotherapy with praziquantel and gentamicin or doxycycline on acute hepatic and intestinal schistosomiasis in BALB/c mice.
    Exp Parasitol. 2025;271:108928.
    PubMed     Abstract available
    
    
    February 2025
14. FREIRE LC, Costa SS, Tedeschi ALF, Santos LMO, et al
    Synthetic peptides derived from hypothetical proteins as potential antigens for the diagnosis of canine visceral leishmaniasis and tegumentary leishmaniasis.
    Exp Parasitol. 2025;270:108914.
    PubMed     Abstract available
    
    
    January 2025
15. CORREA E, Robledo SM, Echeverri F, Quinones W, et al
    In vitro and in vivo leishmanicidal and trypanocidal activities of isoflavans from Tabebuia chrysantha (Jacq.) G. Nicholson timber by-products.
    Exp Parasitol. 2025 Jan 23:108899. doi: 10.1016/j.exppara.2025.108899.
    PubMed     Abstract available
    
    
    
16. PARENTE ROCHA SI, Fernandes VB, Barbosa da Silva WM, Frota LS, et al
    Antileishmanial activity of Hesperetin on Leishmania donovani, in vitro and in silico inhibition of acetylcholinesterase and investigation of the targets sterol C-24 reductase and N-myristoyltransferase.
    Exp Parasitol. 2025 Jan 19:108903. doi: 10.1016/j.exppara.2025.108903.
    PubMed     Abstract available
    
    
    
17. FERREIRA EA, Campos IM, Cajas RA, de Souza Costa D, et al
    In vivo efficacy of uvangoletin from Piper aduncum (Piperaceae) against Schistosoma mansoni and in silico studies targeting SmNTPDases.
    Exp Parasitol. 2025;269:108897.
    PubMed     Abstract available
    
    
    
18. MAZIRE PH, Shingade S, Roy A
    Ritonavir enhances the efficacy of amprenavir: A promising combination therapy by targeting Leishmania DNA topoisomerase I for treatment of visceral leishmaniasis.
    Exp Parasitol. 2025;269:108898.
    PubMed     Abstract available
    
    
    
19. NAGDY YAE, Nabil ZE, El-Shenawy NS, Elkhawass EA, et al
    Antiparasitic and antioxidant effects of selenium nanoparticles on parasitic Trichinellaspiralis.
    Exp Parasitol. 2025;268:108876.
    PubMed     Abstract available
    
    
    December 2024
20. KARIMBAYOVA GN, Gasimov EK, Mahmudov FR, Rzayev FH, et al
    Ultrastructural characteristics of leishmania (L.)tropica (Wright, 1903) and cell-parasite relationships in cutaneous leishmaniasis. Light and electron microscopic study.
    Exp Parasitol. 2024;269:108887.
    PubMed     Abstract available
    
    
    
21. LOBO-ROJAS AE, Delgado-Chacon MA, Valera-Vera EA, Chacon-Arnaude M, et al
    Galactokinase and galactose metabolism in Leishmania spp.
    Exp Parasitol. 2024 Dec 30:108888. doi: 10.1016/j.exppara.2024.108888.
    PubMed     Abstract available
    
    
    
22. DIAS-LOPES G, Goncalves MEP, Cristina de Albuquerque-Melo B, Peixoto JF, et al
    Exploring the binomial BALB/c-Leishmania (Viannia) braziliensis model to assess the in vivo performance of Thor strain subpopulations.
    Exp Parasitol. 2024 Dec 30:108886. doi: 10.1016/j.exppara.2024.108886.
    PubMed     Abstract available
    
    
    
23. DE GOES VC, Brandao-Bezerra L, Neves RH, de Oliveira AV, et al
    Impact of acute schistosomiasis mansoni and concurrent type 1 diabetes on pancreatic architecture in mice.
    Exp Parasitol. 2024 Dec 24:108885. doi: 10.1016/j.exppara.2024.108885.
    PubMed     Abstract available
    
    
    
24. BIGOT S, Ouameur AA, Roy G, Fakhfakh R, et al
    Studies of the FBT family transporters in Leishmania infantum by gene deletion and protein localization.
    Exp Parasitol. 2024 Dec 19:108880. doi: 10.1016/j.exppara.2024.108880.
    PubMed     Abstract available
    
    
    November 2024
25. MAHDY A, Mostafa OMS, Aboueldahab MM, Nigm AH, et al
    ?Antiparasitic activity of Cerastes cerastes venom on Schistosoma mansoni infected mice?.
    Exp Parasitol. 2024 Nov 29:108866. doi: 10.1016/j.exppara.2024.108866.
    PubMed     Abstract available
    
    
    
26. SHIRAZIAN M, Taghipour N, Akhavan AA, Tabaei SJS, et al
    Expression pattern of ARG1 and iNOS genes in macrophages of Rhombomys opimus, BALB/c and C57BL/6 mice exposed to Leishmania major and salivary gland homogenates of Phlebotomus papatasi.
    Exp Parasitol. 2024 Nov 22:108863. doi: 10.1016/j.exppara.2024.108863.
    PubMed     Abstract available
    
    
    
27. HOBLOS R, Khalil K, Karam M, Bazzi S, et al
    The role of NF-kappaB transcription factor in the regulation of cytokine induced thermal hyperalgesia in a Leishmania major model in BALB/c mice.
    Exp Parasitol. 2024;267:108864.
    PubMed     Abstract available
    
    
    
28. FEIZ-HADDAD MH, Moradkhani MA, Sefat F, Ali SA, et al
    The molecular and histopathological investigations of TLR2 rs5743708 and TLR4 (rs4986790 and rs4986791) polymorphisms effects on cutaneous leishmaniasis lesions.
    Exp Parasitol. 2024;267:108857.
    PubMed     Abstract available
    
    
    
29. SHARIFI I, Salarkia E, Dabiri S, Pardakhty A, et al
    Preparation, characterization, and in vivo activity of Gossypium hirsutum niosomes against cutaneous leishmaniasis caused by Leishmania major in a murine model: Parasite burden, gene expression, and histopathological profiling.
    Exp Parasitol. 2024 Nov 4:108859. doi: 10.1016/j.exppara.2024.108859.
    PubMed     Abstract available
    
    
    
30. AJITH Y, Adithya S, Athira KS, Beena V, et al
    Effects of environmental factors on host-parasite interaction patterns in backyard-tethered goats of Kerala, India.
    Exp Parasitol. 2024;266:108846.
    PubMed     Abstract available
    
    
    October 2024
31. TEIXEIRA TL, Teixeira SC, Borges BC, Servato JPS, et al
    Trypanosoma cruzi P21 protein exacerbates Leishmania (L.) amazonensis infection.
    Exp Parasitol. 2024;267:108856.
    PubMed     Abstract available
    
    
    
32. MAHMOUD M, Allam AF, Essawy AE, Shalaby TI, et al
    Therapeutic efficacy of praziquantel loaded-chitosan nanoparticles on juvenile Schistosoma mansoni worms in murine model.
    Exp Parasitol. 2024 Oct 4:108843. doi: 10.1016/j.exppara.2024.108843.
    PubMed     Abstract available
    
    
    August 2024
33. DHULIPALLA M, Chouhan G
    The Nexus between Leishmania & HIV: Debilitating Host Immunity and Hastening Comorbid Disease Burden.
    Exp Parasitol. 2024 Aug 13:108826. doi: 10.1016/j.exppara.2024.108826.
    PubMed     Abstract available
    
    
    July 2024
34. NERY DOS SANTOS Q, Teles DCS, de Araujo GRS, Lima OVA, et al
    Microemulsions strongly promoted the activity of alpha-bisabolol against different Leishmania species and its skin permeation.
    Exp Parasitol. 2024 Jul 31:108808. doi: 10.1016/j.exppara.2024.108808.
    PubMed     Abstract available
    
    
    
35. OAIKHENA EE, Yahaya UA, Abdulsalami SM, Egbe NL, et al
    THE ACTIVITIES OF SUAVEOLOL AND OTHER COMPOUNDS FROM HYPTIS SUAVEOLENS AND MOMORDICA CHARANTIA AGAINST THE AETIOLOGICAL AGENTS OF AFRICAN TRYPANOSOMIASIS, LEISHMANIASIS AND MALARIA.
    Exp Parasitol. 2024 Jul 21:108807. doi: 10.1016/j.exppara.2024.108807.
    PubMed     Abstract available
    
    
    
36. SHAFI MT, Bamra T, Roy C, Kumar M, et al
    Mevalonate kinase of Leishmania donovani promotes its survival and plays a pivotal role in pathogenesis.
    Exp Parasitol. 2024 Jul 21:108800. doi: 10.1016/j.exppara.2024.108800.
    PubMed     Abstract available
    
    
    
37. LOYO R, Gomes ECS, Pieri OS, Oliveira ECA, et al
    Kato-Katz slide preservation technique: extension of viability and the benefits for schistosomiasis control programs.
    Exp Parasitol. 2024 Jul 21:108802. doi: 10.1016/j.exppara.2024.108802.
    PubMed     Abstract available
    
    
    May 2024
38. WANG X, Giri BR, Cui Z, Munkhjargal T, et al
    Development of a Gaussia luciferase immunoprecipitation assay for detecting Schistosoma japonicum infection.
    Exp Parasitol. 2024 May 13:108776. doi: 10.1016/j.exppara.2024.108776.
    PubMed     Abstract available
    
    
    April 2024
39. OSADA Y, Shimizu S, Morita K, Gaballah EM, et al
    Helminth-induced impairment of humoral immunity differently contribute to their anti-arthritic effects in mice: Comparison of Schistosoma mansoni and Trichinella spiralis.
    Exp Parasitol. 2024 Apr 9:108752. doi: 10.1016/j.exppara.2024.108752.
    PubMed     Abstract available
    
    
    March 2024
40. INGALE P, Singh S
    Elucidating miR-146a-3p as a key player in autophagy and lipid metabolism in Leishmania major infection.
    Exp Parasitol. 2024;260:108745.
    PubMed     Abstract available
    
    
    
41. GONZALEZ-MATOS M, Aguado ME, Izquierdo M, Monzote L, et al
    Compounds with potentialities as novel chemotherapeutic agents in leishmaniasis at preclinical level.
    Exp Parasitol. 2024 Mar 20:108747. doi: 10.1016/j.exppara.2024.108747.
    PubMed     Abstract available
    
    
    
42. PEREIRA IAG, Freitas CS, Camara RSB, Jesus MM, et al
    Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis species.
    Exp Parasitol. 2024 Mar 19:108743. doi: 10.1016/j.exppara.2024.108743.
    PubMed     Abstract available
    
    
    February 2024
43. BALIOVA M, Jursky F
    Manganese- and zinc-coordinated interaction of Schistosoma japonicum glutathione S-transferase with neurotransmitter transporters GlyT1 and GAT3 in vitro.
    Exp Parasitol. 2024;259:108721.
    PubMed     Abstract available
    
    
    
44. AKRAMOVA F, Shakarbaev U, Paluaniyazova D, Akbarov A, et al
    Assessing the effectiveness of fenbendazole supramolecular complexes against schistosomiasis, monieziosis and parabronemosis in sheep.
    Exp Parasitol. 2024;258:108714.
    PubMed     Abstract available
    
    
    
45. DEEPACHANDI B, Weerasinghe S, Gunathileka H, Soysa P, et al
    In vitro growth of Leishmania parasites from biopsy samples of suspected cutaneous and visceral leishmaniasis cases in Sri Lanka: An observational study.
    Exp Parasitol. 2024 Feb 11:108710. doi: 10.1016/j.exppara.2024.108710.
    PubMed     Abstract available
    
    
    
46. PAIVA MACHADO F, da Silva Rangel L, Farias Gomes K, Albuquerque Dos Santos JA, et al
    Potential of Ocotea indecora (Schott) Mez essential oil nanoemulsion in schistosomiasis control: Molluscicidal effects.
    Exp Parasitol. 2024 Feb 8:108717. doi: 10.1016/j.exppara.2024.108717.
    PubMed     Abstract available
    
    
    
47. DAWOOD WA, Fisher G, Kinnen F, Anzenhofer C, et al
    Activity of alkoxyamide-based histone deacetylase inhibitors against Plasmodium falciparum malaria parasites.
    Exp Parasitol. 2024 Feb 8:108716. doi: 10.1016/j.exppara.2024.108716.
    PubMed     Abstract available
    
    
    
48. ROSA AAD, Brandao-Bezerra L, Correa CL, Amaral G Da-Silva S, et al
    Changes in splenic tissue and immune response profile of Schistosoma mansoni infected mice submitted to chronic ethanol intake.
    Exp Parasitol. 2024 Feb 1:108706. doi: 10.1016/j.exppara.2024.108706.
    PubMed     Abstract available
    
    
    January 2024
49. ZHANG QZ, Liu JH, Gao YR, Liang J, et al
    Effect of macrophage polarization on parasitic protection against type 1 diabetes mellitus.
    Exp Parasitol. 2024;256:108649.
    PubMed     Abstract available
    
    
    December 2023
50. KUMAR V, Kumari S, Ranjan R, Kumar A, et al
    In vitro antileishmanial activity of thioridazine on amphotericin B unresponsive/ sensitive Leishmania donovani promastigotes and intracellular amastigotes.
    Exp Parasitol. 2023 Dec 22:108688. doi: 10.1016/j.exppara.2023.108688.
    PubMed     Abstract available
    
    
    
51. WIJNANT GJ, Moulik S, Chatterjee K, Das NK, et al
    Dermal microdialysis: A method to determine drug levels in the skin of patients with Post kala-azar dermal leishmaniasis (PKDL).
    Exp Parasitol. 2023 Dec 17:108687. doi: 10.1016/j.exppara.2023.108687.
    PubMed     Abstract available
    
    
    November 2023
52. DE LUNA ROCHA TC, Dos Santos Lima MJ, Nunes do Nascimento JL, Ferreira de Oliveira J, et al
    Development and evaluation of the in vitro schistosomicidal activity of solid dispersions based on 2-(-5-bromo-1-H-indole-3-yl-methylene)-N-(naphthalene-1-ylhydrazine-carbothiamide.
    Exp Parasitol. 2023 Nov 14:108626. doi: 10.1016/j.exppara.2023.108626.
    PubMed     Abstract available
    
    
    
53. PATIDAR A, Shukla D, Bodhale N, Saha B, et al
    TLR2, TLR3, TLR4, TLR9 and TLR11 expression on effector CD4(+) T-cell subsets in Leishmania donovani infection.
    Exp Parasitol. 2023 Nov 8:108645. doi: 10.1016/j.exppara.2023.108645.
    PubMed     Abstract available
    
    
    October 2023
54. SANTOS EV, Damasceno JD, Obonaga R, Rosales R, et al
    The dynamic subcellular localisation of Rad1 is cell cycle dependent in Leishmania major.
    Exp Parasitol. 2023 Oct 31:108639. doi: 10.1016/j.exppara.2023.108639.
    PubMed     Abstract available
    
    
    
55. GOMES DA SILVA B, de Sousa IRA, do Nascimento Santos LA, Dos Santos VHB, et al
    Potential of pharmaceutical formulation based on Morinda citrifolia extract for the treatment of schistosomiasis.
    Exp Parasitol. 2023 Oct 14:108617. doi: 10.1016/j.exppara.2023.108617.
    PubMed     Abstract available
    
    
    September 2023
56. PARN S, Lewis G, Knight M
    Inhibition of carbonic anhydrase using aspirin is a novel method to block schistosomiasis infection of the parasitic trematode, Schistosoma mansoni, in the intermediate snail host, Biomphalaria glabrata.
    Exp Parasitol. 2023;254:108618.
    PubMed     Abstract available
    
    
    
57. SHARIFI F, Mohamadi N, Afgar A, Oliaee RT, et al
    Anti-leishmanial, immunomodulatory and additive potential effect of Piperine on Leishmania major: The in silico and in vitro study of Piperine and its combination.
    Exp Parasitol. 2023 Sep 2:108607. doi: 10.1016/j.exppara.2023.108607.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parasitic Diseases is free of charge.